Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 20 Show results per page	View Search Criteria \| Help With Results


1.		CryoSpray Ablation(tm)in Malignant Airway Disease to Determine Safety, and Tissue Effect in the Lung (ICE the MAD)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Treatment				Active				18 and over				Pharmaceutical / Industry				08-0106 NCT00748085


2.		AMR PH GL 2007 CL 001 Phase 3 Trial in Patients With Small Cell Lung Cancer After Failure of First-Line Chemotherapy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 and over				Pharmaceutical / Industry				AMR PH GL 2007 CL 001 NCT00547651

Last Modified: 10/3/2008 First Published: 3/7/2008


3.		Phase III Randomized Study of Three Different Thoracic Radiotherapy Regimens in Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 and over				NCI				CALGB-30610 CALGB 30610, RTOG 0538, CALGB-30610, NCT00632853


4.		A Phase 1/2a Study of ABT-263 in Subjects With Small Cell Lung Cancer (SCLC) or Other Non-Hematological Malignancies

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Biomarker/Laboratory analysis, Treatment				Active				18 and over				Pharmaceutical / Industry				M06-822 NCT00445198

Last Modified: 5/22/2008 First Published: 5/4/2007


5.		Phase II Pilot Study of Irradiated Allogeneic Related Donor Lymphocyte Infusion in Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Biomarker/Laboratory analysis, Treatment				Active				Any age				NCI				CINJ-3330 NCT00161187

Last Modified: 10/5/2008 First Published: 5/1/2007


6.		Phase II Study of Dasatinib in Patients With Relapsed Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				NCI				CALGB-30602 CALGB-30602, CALGB 30602, NCT00470054


7.		Phase II Study for Previously Untreated Subjects With Non Small Cell Lung Cancer (NSCLC) or Small Cell Lung Cancer (SCLC)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				Pharmaceutical / Industry				CA184-041 NCT00527735

Last Modified: 10/10/2008 First Published: 11/1/2007


8.		Phase II Study of Filgrastim (G-CSF) and Pegfilgrastim in Patients Undergoing Radiotherapy and Chemotherapy Comprising Cisplatin and Etoposide Followed by Adjuvant Cisplatin and Etoposide for Limited Stage Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Supportive care, Treatment				Active				18 and over				NCI				RTOG-0623 RTOG 0623, RTOG-0623, NCT00554463


9.		Autologous PBHCT Followed by Dendritic Cell p53 Vaccination & Adoptive T Cell Transfer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				Other				MCC-14955 USFIRB#105632, NCT00609583


10.		Phase I Study of IV DOTAP: Cholesterol-Fus1 in Non-Small-Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Active				Not specified				NCI, Other				ID00-123 NCT00059605

Select All on One Page


					1 2 Next >

| | | | | | | |

A Service of the National Cancer Institute